-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
-
Summary
-
Adial Pharmaceuticals, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2021 to Q1 2023.
- Adial Pharmaceuticals, Inc. Deferred Income Tax Liabilities, Net for the quarter ending March 31, 2023 was $22.9K, a 2.15% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)